Gotowe bibliografie tematyczne / Cervical Cancer

Gotowa bibliografia na temat „Cervical Cancer”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 6 września 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cervical Cancer”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cervical Cancer"

1

S Kadam, Sachin, i Tejaswini Kadam. "Endometrial Cancer with Cervical Extension Masquerading as Cervical Cancer". Cancer Research and Cellular Therapeutics 6, nr 3 (16.05.2022): 01–03. http://dx.doi.org/10.31579/2640-1053/118.

Pełny tekst źródła
Streszczenie:
The incidence and prevalence of endometrial cancer is less as compared to cervical cancer. Worldwide, in 2018, near about 382000 new cases of endometrial cancer were diagnosed and around 90000 women were died from the disease
Style APA, Harvard, Vancouver, ISO itp.
2

Yang, Nan, Esther R. Nijhuis, Haukeline H. Volders, Jasper J. H. Eijsink, Ágnes Lendvai, Bo Zhang, Harry Hollema, Ed Schuuring, G. Bea A. Wisman i Ate G. J. van der Zeea. "Gene Promoter Methylation Patterns throughout the Process of Cervical Carcinogenesis". Analytical Cellular Pathology 32, nr 1-2 (1.01.2010): 131–43. http://dx.doi.org/10.1155/2010/306087.

Pełny tekst źródła
Streszczenie:
Objectives: To determine methylation status of nine genes, previously described to be frequently methylated in cervical cancer, in squamous intraepithelial lesions (SIL).Methods: QMSP was performed in normal cervix, low-grade (L)SIL, high-grade (H)SIL, adenocarcinomas and squamous cell cervical cancers, and in corresponding cervical scrapings.Results: Only CCNA1 was never methylated in normal cervices and rarely in LSILs. All other genes showed methylation in normal cervices, with CALCA, SPARC and RAR-β2 at high levels. Methylation frequency of 6 genes (DAPK, APC, TFPI2, SPARC, CCNA1 and CADM1) increased with severity of the underlying cervical lesion. DAPK showed the highest increase in methylation frequency between LSIL and HSIL (10% vs. 40%, p < 0.05), while CCNA1 and TFPI2 were most prominently methylated in cervical cancers compared to HSILs (25% vs. 52%, p < 0.05, 30% vs. 58%, p < 0.05). CADM1 methylation in cervical cancers was related to depth of invasion (p < 0.05) and lymph vascular space involvement (p < 0.01), suggesting a role in invasive potential of cervical cancers. Methylation ratios in scrapings reflected methylation status of the underlying lesions (p < 0.05).Conclusion: Methylation of previously reported cervical cancer specific genes frequently occurs in normal epithelium. However, frequency of methylation increases during cervical carcinogenesis, with CCNA1 and DAPK as the best markers to distinguish normal/LSIL from HSIL/cancer lesions.
Style APA, Harvard, Vancouver, ISO itp.
3

Isakova, Dilnoza, Zebiniso Inakova, Ranokhon Solieva, Matkarimov Bakhtiyorjon, Yorkinoy Farmankulova i Dilfuzahon Mamarasulova. "Clinical Echocolpocsopy Features Of Cervical Cancer". American Journal of Medical Sciences and Pharmaceutical Research 02, nr 07 (31.07.2020): 123–29. http://dx.doi.org/10.37547/tajmspr/volume02issue07-16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Singh Randhawa, Amritjot. "Metastatic Breast Cancer to the Uterine Cervix Mimicking Cervical Cancer". Indian Journal of Cancer Education and Research 8, nr 1 (1.06.2020): 49–52. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

AziziKia, Hani, Hamidreza Didar, Azin Teymourzadeh, Amin Nakhostin-Ansari, Pooya Jafari Doudaran, Bahareh Ferasatifar, Armin Hoveidaei i Gholamreza Roshandel. "Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry". Archives of Iranian Medicine 26, nr 1 (1.01.2023): 1–7. http://dx.doi.org/10.34172/aim.2023.01.

Pełny tekst źródła
Streszczenie:
Background: Gynecologic cancers, including neoplasms of the cervix and uterine, are the fourth most common malignancies, causing 3.46% of deaths in women aged 15 to 59. Objectives: We aimed to report the Iranian National Population-based Cancer Registry (INPCR) results for Cervical and Uterine cancers in 2017. Methods: The total population of Iran in 2017 was 80881792. INPCR collected data on cervical and uterine cancer incidence from 31 provinces of Iran. In this project, we retrospectively examined all the country’s regions in terms of screening for the existence of these two cancers. The registry data bank in Iran was used. Results: Overall, 3481 new cervical and uterine cancer cases were registered in INPCR, including 842 cases of cervical cancer (with a crude rate of 1.04) and 2639 cases of uterine cancer (with a crude rate of 3.26). The average age-standardized incidence rate (ASR) was 0.99 for cervical cancer and 3.29 for uterine cancer. Out of 3481 new cervical and uterine cancer cases, 2887 were registered with pathological findings and 594 without pathological confirmation. In cervical cancers, the highest rate was related to squamous cell carcinoma, with 486 cases (57.72%). Conclusion: Our results showed that Iran is a low-risk area for the incidence of cervical and uterine cancers. In this study, the highest rate of cervical cancer was related to squamous cell carcinoma, confirming previous reports. However, this rate was lower than previous studies and suggested an increase in other types of cervical cancer in Iran.
Style APA, Harvard, Vancouver, ISO itp.
6

H.K, Dr Sharath Kumar. "Immuno-Histochemical Study of P16INK4A in Cervical Intraepithelial Neoplasia and Cervical Cancer". Journal of Medical Science And clinical Research 05, nr 01 (8.01.2017): 15415–22. http://dx.doi.org/10.18535/jmscr/v5i1.37.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Der, EM, K. Adu-Bonsaffoh, Y. Tettey, RA Kwame-Aryee, JD Seffah, H. Alidu i RK Gyasi. "Clinico-pathological characteristics of cervical cancer in Ghanaian women". Journal of Medical and Biomedical Sciences 3, nr 3 (13.01.2015): 27–32. http://dx.doi.org/10.4314/jmbs.v3i3.5.

Pełny tekst źródła
Streszczenie:
Cervical cancer is a major cause of cancer related mortality in the developing countries, although preventable. The aim of this study was to use a retrospective descriptive study to determine the prevalence and the clinico-pathological characteristics of cervical cancer among genital tract ma-lignancies. This study reviewed all histologically confirmed female genital tract malignancies for cervical cancers from January 2002 to December 2011. The clinico-pathological features of women with cervical cancer were analyzed using SPSS software (version 18). A total of 1011(70.8%) out of 1,427 female genital tract malignancies were cervical cancers. The average prevalence of cervical cancer was 71.0%. The mean age of women with cervical cancer was 57.8(SD=13.8) years. The youngest patient was 22 years. The commonest (76.9%) presentation was bleeding per vaginalm followed by fungating cervical masses (12.4%). Majority (88.9%) of the bleeding were unprovoked and in postmenopausal women (98.8%). The major types of cervical cancers were Squamous cell carcinoma (SCC) (90.1%) and adenocarcinoma (5.8%), both were common in the elderly. The com-mon histological subtypes of cervical cancers in the study were; keratinizing SCC (73.3%), non-keratinizing SCC (14.7%), endometroid adenocarcinoma (4.5%), adenosquamous carcinoma (2.6%) and basaloid SCC (1.4%). This study found high prevalence of cervical cancer among female geni-tal tract cancers in Accra Ghana. The women were relatively older and presented with advanced stage of the disease. SCC was the major histological type of cervical cancer.Keywords: Ghana, cervical cancer, postmenopausal, women, premalignant, genital tract
Style APA, Harvard, Vancouver, ISO itp.
8

Iram, Ayesha. "Cancer Screening Technology and Attitude of Women Towards Cervical Cancer". TEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH 9, nr 3 (30.07.2022): 145–67. http://dx.doi.org/10.21522/tijar.2014.09.03.art013.

Pełny tekst źródła
Streszczenie:
Cervical cancer claims over a quarter of a million lives of women annually worldwide. It is believed to be the second most common cancer among women worldwide. Screening is used to detect precancerous changes or early cancers before signs or symptoms of cancer occur. The first case of cervical cancer was founded in the 1970s by Harald Zur Hausen. It is believed to be the second most common cancer among women worldwide. Females becoming sexually active in early age with multiple partners are on high risk. Virtually all cervical cancers are associated with human papilloma viruses (HPV). This study was conducted to understand the levels of knowledge and attitudes of women towards cervical cancer screening in Al Khan Dubai.It assessed the knowledge and attitudes of women about cervical cancer prevention. 70% of the sexually active women really need to go for cancer screening. It shows that 66% of women in al khan are being affected due to lifestyle and it is affecting women’s decision in relation to cervical cancer screening. To improve cervical cancer screening in al khan area, women should be given more information, motivation, awareness, and sensitization, in order to encourage them to go for a cervical cancer screening. Keywords: Cervix, High risk, HPV, Pre-screening methods, Women.
Style APA, Harvard, Vancouver, ISO itp.
9

Dayanand Katke, Rajshree, i Deepti Prasad. "Cervical Cancer Prevention: Current Scenario". Acta Scientific Cancer Biology 4, nr 2 (18.01.2020): 01–03. http://dx.doi.org/10.31080/ascb.2020.04.cervical-cancer-prevention-current-scenario.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Boisen, Michelle, i Richard Guido. "Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer". Clinical Obstetrics & Gynecology 66, nr 3 (25.07.2023): 500–515. http://dx.doi.org/10.1097/grf.0000000000000790.

Pełny tekst źródła
Streszczenie:
Discussion of treatment strategies for cervical cancer precursors, review of medical therapies and emerging therapeutics for treatment of cervical cancers, and updates on new approaches to treating early-stage cervical cancers.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Cervical Cancer"

1

Ibrahim, Emad Moussa. "CD44 in cervical cancer". Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269370.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Thornton, Julia Susan. "Screening for cervical cancer". Thesis, City University London, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241442.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Nevin, James. "Pregnancy-associated cervical cancer". Thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/26272.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ratima, Keri, i n/a. "Cervical cancer in Maori women". University of Otago. Dunedin School of Medicine, 1994. http://adt.otago.ac.nz./public/adt-NZDU20070601.112003.

Pełny tekst źródła
Streszczenie:
This thesis is concerned with cervical cancer amongst New Zealand women, particularly Maori women. Maori women have an alarmingly high incidence of cervical cancer, approximately three times higher than non-Maori women. Maori women experience one of the highest rates of cervical cancer in the world. Chapter one, two and three form the introductory section of the thesis, Section A. Chapter one provides an overview of cervical cancer incidence in the world, followed by a more detailed analysis of the occurrence of cervical cancer in New Zealand and a discussion of the aetiological factors of cervical cancer. Cervical screening is discussed in Chapter two. The ethnic differences in incidence and mortality of cervical cancer between Maori and non-Maori and possible reasons for these differences are studied in Chapter three. Section B consists of the original work undertaken. A pilot study (Chapter four) was conducted to trial the methods for the national study (Chapter five). The national study was a retrospective review of the cervical smear histories of Maori women first diagnosed with invasive cervical cancer over a recent two year period in order to investigate why Maori women have not had their disease detected by screening and treated at the intraepithelial stage. Maori women�s knowledge of and attitudes towards cervical screening were obtained in a survey in Ruatoria (Chapter six). Section C concludes with a chapter (Chapter seven) on the conclusions and recommendations based on the material reviewed and the work undertaken.
Style APA, Harvard, Vancouver, ISO itp.
5

Govorukhina, Natalia I. "Biomarker discovery for cervical cancer". [S.l. : Groningen : s.n. ; University Library of Groningen] [Host], 2007. http://irs.ub.rug.nl/ppn/305362089.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Roeder, Geraldine Elizabeth. "Gene therapy for cervical cancer". Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268704.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Li, Xing. "Novel brachytherapy techniques for cervical cancer and prostate cancer". Diss., University of Iowa, 2015. https://ir.uiowa.edu/etd/1682.

Pełny tekst źródła
Streszczenie:
Intensity-modulated brachytherapy techniques, compensator-based intensity modulated brachytherapy (CBT) and interstitial rotating shield brachytherapy (I-RSBT), are two novel conceptual radiation therapies for treating cervical and prostate cancer, respectively. Compared to conventional brachytherapy techniques for treating cervical cancer, CBT can potentially improve the dose conformity to the high-risk clinical target volume (CTV) of the cervix in a less invasive approach. I-RSBT can reduce the dose delivered to the prostate organ at risks (OARs) with the same radiation dose delivered to the prostate CTV. In this work, concepts and prototypes for CBT and I-RSBT were introduced and developed. Preliminary dosimetric measurements were performed for CBT and I-RSBT, respectively. A CBT prototype system was constructed and experimentally validated. A prototype cylindrical compensator with eight octants, each with different thicknesses, was designed. Direct metal laser sintering (DMLS) was used to construct CoCr and Ti compensator prototypes, and a 4-D milling technique was used to construct a Ti compensator prototype. Gafchromic EBT2 films, held by an acrylic quality assurance (QA) phantom, were irradiated to approximately 125 cGy with an electronic brachytherapy (eBT) source for both shielded and unshielded cases. The dose at each point on the films were calculated using a TG-43 calculation model that was modified to account for the presence of a compensator prototype by ray-tracing. With I-RSBT, a multi-pass dose delivery mechanism with prototypes was developed. Dosimetric measurements for a Gd-153 radioisotope was performed to demonstrate that using multiple partially shielded Gd-153 sources for I-RSBT is feasible. A treatment planning model was developed for applying I-RSBT clinically. A custom-built, stainless steel encapsulated 150 mCi Gd-153 capsule with an outer length of 12.8 mm, outer diameter of 2.10 mm, active length of 9.98 mm, and active diameter of 1.53 mm was used. A partially shielded catheter was constructed with a 500 micron platinum shield and a 500 micron aluminum emission window, both with 180° azimuthal coverage. An acrylic phantom was constructed to measure the dose distributions from the shielded catheter in the transverse plane using Gafchromic EBT3 films. Film calibration curves were generated from 50, 70, and 100 kVp x-ray beams with NIST-traceable air kerma values to account for energy variation. In conclusion, CBT, which is a non-invasive alternative to supplementary interstitial brachytherapy, is expected to improve dose conformity to bulky cervical tumors relative to conventional intracavitary brachytherapy. However, at the current stage, it would be time-consuming to construct a patient-specific compensator using DMLS, and the quality assurance of the compensator would be difficult. I-RSBT is a promising approach to reducing radiation dose delivered to prostate OARs. The next step in making Gd-153 based I-RSBT feasible in clinic is developing a Gd-153 source that is small enough such that the source, shield, and catheter all fit within a 16 guage needle, which has a 1.65 mm diameter.
Style APA, Harvard, Vancouver, ISO itp.
8

Gunnell, Anthony S. "Risk factors for cervical cancer development /". Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-437-2/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

張德凱 i Dekai Zhang. "Telomerase activation in human cervical cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1998. http://hub.hku.hk/bib/B31238038.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ng, Grace. "Genomic investigations of cervical cancer progression". Thesis, University of Cambridge, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.613036.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Cervical Cancer"

1

Dunleavey, Ruth. Cervical Cancer. New York: John Wiley & Sons, Ltd., 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

de la Garza-Salazar, Jaime G., Flavia Morales-Vásquez i Abelardo Meneses-Garcia, red. Cervical Cancer. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Keppler, Daniel, i Athena W. Lin, red. Cervical Cancer. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2013-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hasan, Heather. Cervical cancer. New York: Rosen, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Royal College of Obstetricians and Gynaecologists., red. Cervical smears: Preventing cervical cancer. London: RCOG, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Austoker, Joan. Cervical cancer screening. [London]: Cancer Research Campaign, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Cervical Cancer"

1

de la Garza-Salazar, Jaime G., Abelardo Meneses-García, Oscar Arrieta-Rodríguez, José Luis Aguilar-Ponce i Paula Juarez-Sánchez. "Introduction". W Cervical Cancer, 1–17. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

González-Enciso, Aarón, Salim Abraham Barquet-Muñoz i Milagros Pérez-Quintanilla. "Primary Surgical Treatment of Cervical Cancer". W Cervical Cancer, 151–62. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Montalvo-Esquivel, Gonzalo, Milagros C. Pérez-Quintanilla, Angel Herrera-Gómez, Francisco Javier Alcalá-Prieto, Flavia Morales-Vásquez i Horacio Noé López Basave. "Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer". W Cervical Cancer, 163–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mota-García, Aida, Monika Blake-Cerda, Bonifacio Ramón-Ortega, Roque Alberto Guadarrama-Fleites i Guadalupe Elizabeth Trejo-Durán. "Radiotherapy in Cervical Cancer". W Cervical Cancer, 177–97. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Jorge Martínez-Tlahuel, Julio César Velasco-Rodríguez, Horacio N. López-Basave i Jaime G. de la Garza-Salazar. "Systemic Treatment of Cervical Cancer". W Cervical Cancer, 199–214. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Marquez-Manriquez, Juan P., Erik Ramos i Dolores Gallardo-Rincón. "Immuno-Oncology in Cervical Cancer". W Cervical Cancer, 215–23. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Allende-Pérez, Silvia, Emma Verástegui-Avilés, Dana A. Pérez-Camargo, Georgina Domínguez-Ocadio i Frank D. Ferris. "Palliative Care in Cervical Cancer Patients". W Cervical Cancer, 225–52. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Julio César Velasco-Rodríguez, Horacio N. López-Basave i Jaime G. de la Garza-Salazar. "Special Conditions and Follow-Up in Cervical Cancer". W Cervical Cancer, 253–68. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Reynoso-Noverón, Nancy, Adriana Peña-Nieves, Maryori Ortiz Rodríguez i Alejandro Mohar-Betancourt. "Cervical Cancer Epidemiology". W Cervical Cancer, 19–33. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Astudillo-de la Vega, H., E. Ruiz-Garcia, C. Lopez-Camarillo, Jaime G. de la Garza-Salazar, A. Meneses-Garcia i L. Benitez-Bribiesca. "Malignant Transforming Mechanisms of Human Papillomavirus". W Cervical Cancer, 35–56. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Cervical Cancer"

1

Vemanamandhi, Priyanka. "A Rare mimicker of Cervical Cancer- Cervical Amebiasis". W 10th National Conference of Asia Oceania Research Organisation on Genital Infections and Neoplasia, India. AOGIN 2021, 2021. http://dx.doi.org/10.7869/aogin68.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Srivastava, Astha, Bindiya Gupta, Vikas Lakha i Shilpa Singh. "Study on cervical cancer screening amongst nurses". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685284.

Pełny tekst źródła
Streszczenie:
Objective: To study the knowledge, attitude and practice of nurses at tertiary centre regarding cervical cancer screening. Material and Methods: Validated questionnaire was circulated amongst staff nurses at tertiary care centre after taking informed consent. Results and Discussion: Cancer of cervix is the most common genital tract malignancy in female and it is ranked second to breast cancer. It has a positive association with HPV infection. Cervical cancer incidence and mortality have declined substantially following introduction of screening programmes. This present study investigated the knowledge, attitude and practice of nurses at GTB Hospital towards cervical cancer risk factors, sign & symptoms and screening as they are important health professionals. In our study, the results showed that 99% of respondents were aware of Pap smear as screening programme and about 60-70% were aware of HPV as positive organism, but most of them never had a Pap smear done before. Majority of them did not know VIA, VILI and colposcopy as screening techniques. Conclusion: It may thus be recommended that institutions should periodically organize seminars and training for health personnel especially the nurses which form a group of professionals that should give health education to women about cervical cancer.
Style APA, Harvard, Vancouver, ISO itp.
3

"Aspirin and Cervical Cancer". W 2016 International Conference on Biological and Environmental Science. Universal Researchers, 2016. http://dx.doi.org/10.17758/ur.u0616230.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Bran, Liliana. "CERVICAL CANCER CLUSTERING IN ARAD AND CERVICAL CANCER SCREENING PROGRAMMES IN ROMANIA". W 5th SGEM International Multidisciplinary Scientific Conferences on SOCIAL SCIENCES and ARTS SGEM2018. STEF92 Technology, 2018. http://dx.doi.org/10.5593/sgemsocial2018h/31/s13.074.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Pâslaru, Ana-Maria, Ana Fulga, Elena Niculet, Laura Florentina Rebegea, Iuliu Fulga i Anamaria Ciubara. "SUPRACLAVICULAR AND CERVICAL LYMPH NODE METASTASES HAVING CERVICAL CANCER AS STARTING POINT. CASE PRESENTATION". W The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.10.

Pełny tekst źródła
Streszczenie:
Introduction: Cervical cancer is the fourth most frequently found cancer among women worldwide. Numerous studies have underlined that persistent infection with human papilloma virus is the most important risk factor, two strains of the same virus – 16 and 18 being responsible for approximately 70% of the cases. Cervical cancer rarely metastasizes in the cervical lymph nodes and this indicates a poor prognosis. Literature data reports an incidence for left supraclavicular M1LYm of 0.1-1.5%. Material and Method: We bring attention to the case of a 44-year-old patient from the rural area who was diagnosed in January 2019 with stage IIIB cervical cancer, represented morphologically by a poorly differentiated squamous cell carcinoma. When admitted, the patient presented clinically with vaginal hemorrhage, intense abdominal and pelvic pain, fatigue, a dynamic, significant weight loss. The physiological personal history revealed nine pregnancies, the first one when she was 16. After pretherapeutic evaluation, the multidisciplinary committee decides performing simultaneous radio-chemotherapy with platinum salts. During the second week of treatment clinical examination revealed left cervical and supraclavicular adenopathy, both documented through imaging evaluation. Lymph node biopsy is done and its histopathological aspect, correlated with the immunohistochemistry profile supports the diagnosis of poorly differentiated squamous cell carcinoma lymph node metastasis. The initial treatment scheme is maintained, the patient being discharged with clinical remission of cervical and supraclavicular lymph node metastasis. Conclusions: The peculiarity of the case is determined by the distant metastases in the left cervical and supraclavicular lymph nodes, a rare finding during treatment, which was associated with a poor prognosis; in this case treatment was done for palliative purposes. Rapid diagnosis is the main factor that conditions the therapeutic results and chances for healing.
Style APA, Harvard, Vancouver, ISO itp.
6

Amengual, J., A. Torrent, AM Quintero Duarte i M. Ruiz. "385 Undiagnosed invasive cervical cancer". W ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.27.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Jiamset, Ingporn, Kulisara Nanthamongkolkul i Rakchai Buhachat. "Ovarian transposition and cervical cancer". W The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.c27.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Herman, B. "APPLICATIONS OF LASER OPTICAL MICROSCOPIC TECHNIQUES IN DECIPHERING DISEASE SPECIFIC MECHANISMS AND DIAGNOSIS". W Biomedical Optical Spectroscopy and Diagnostics. Washington, D.C.: Optica Publishing Group, 2006. http://dx.doi.org/10.1364/bosd.1996.ft5.

Pełny tekst źródła
Streszczenie:
Accumulating evidence strongly associates human papillomavirus infection with the development of cervical cancers. However, it has also become increasingly clear that HPV infections of the cervix span a wide clinical spectrum from benign lesions to precancerous lesions, with only a minority of infections resulting in invasive cancers, although the reasons for this are not clear. Longitudinal epidemiologic studies using cytologic methods to detect HPV infection have shown that the majority of women infected with HPV will regress spontaneously. In addition, age-stratified data for rates of HPV positivity from cross-sectional studies also suggest that many women clear the infection spontaneously. These results support the concept that many women may be only transiently infected with HPV during their life span and only in women with persistent HPV infection does cervical cancer progress. In addition to persistence of HPV infection, recent epidemiological studies indicate that the amount of high-risk HPV (viral load or HPV gene copy number) in cervicovaginal epithelial cells may be a risk factor for cervical cancer. Thus, a technique which could detect, genotype and quantitate HPV in smears of cervicovaginal epithelial cells would be of major import in assessment of patient clinical status as well as in epidemiological studies relating HPV infection to cervical cancer.
Style APA, Harvard, Vancouver, ISO itp.
9

Vaidya, Sarayoo Ravishankar. "112 Villages against cervical cancer: improving India’s cervical cancer burden by empowering ASHA workers". W Leaders in Healthcare Conference, 17–20 November 2020. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/leader-2020-fmlm.112.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Banila, C., B. Nedjai, C. Reuter, K. Cuschieri, G. Clifford i A. Lorincz. "77 Cervical pre-cancer vs invasive cancer: molecular differentiation with potential of improving cervical cancer screening worldwide". W IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.77.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Cervical Cancer"

1

Wilbur, David C., Barbara A. Crothers, John H. Eichhorn, Min S. Ro i Jeffrey A. Gelfand. Internet-Based Cervical Cancer Screening Program. Fort Belvoir, VA: Defense Technical Information Center, maj 2008. http://dx.doi.org/10.21236/ada486866.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Ciapponi, Agustín. What is the effectiveness of interventions targeted at women to improve the uptake of cervical cancer screening? SUPPORT, 2016. http://dx.doi.org/10.30846/1611112.

Pełny tekst źródła
Streszczenie:
World-wide, cervical cancer is the second most common cancer in women and more than 85% of women dying from cervical cancer live in the developing world. Increasing the uptake of screening, alongside increasing informed choice, is key to controlling this disease through prevention and early detection. Methods of encouraging women to undergo cervical screening include invitations to screening; reminders to attend screening; education to increase knowledge of screening programmes or of cervical cancer; message framing (positive or negative messages about screening); counselling regarding barriers to screening; risk factor assessment of individuals; procedures, such as making the screening process easier; and economic interventions, such as incentives to attend screening.
Style APA, Harvard, Vancouver, ISO itp.
3

Hoeijmakers, Yvonne M. Cervical biopsy after chemoradiation for locally advanced cervical cancer to identify residual disease: a retrospective cohort study. Science Repository OÜ, marzec 2019. http://dx.doi.org/10.31487/j.jso.2019.01.001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Yelena, Gorina, i Elgaddal Nazik. Patterns of Mammography, Pap Smear, and Colorectal Cancer Screening Services Among Women Aged 45 and Over. National Center for Health Statistics, czerwiec 2021. http://dx.doi.org/10.15620/cdc:105533.

Pełny tekst źródła
Streszczenie:
This study examines and compares sociodemographic, health status, and health behavior patterns of screening for breast cancer, cervical cancer, and colorectal cancer among women aged 45 and over in the United States.
Style APA, Harvard, Vancouver, ISO itp.
5

Zou, Yihua, Fangqin Tong, Meng Guan, Chun Bi i Xia Wang. Efficacy and safety of Anti-angiogenesis combined with chemoradiotherapy in the treatment of locally advanced cervical cancer: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0077.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To Systematicly evaluate of the clinical efficacy and safety of the combination of anti-angiogenesis and simultaneous radiotherapy in the treatment of cervical cancer. Condition being studied: Locally advanced cervical cancer. We searched databases including PubMed, Cochrane Library, Embase, Web of Science CNKI, Wanfang, VIP and CBM, and the International Clinical Trial Registry Platform (ICTRP) and the Chinese Clinical Registry(ChiCTR) to collect the clinical studies about the randomized controlled trial (RCTS) of anti-angiogenic drugs (mainly Endu, apatinib and bevacizumab) combined with chemoradiotherapy in the treatment of cervical cancer. The time limit is from the establishment of the database to April 2022. RevMan 5.4 software was used to analyze the short-term efficacy and the incidence of adverse reactions.
Style APA, Harvard, Vancouver, ISO itp.
6

Guo, Ying, Linlin Ma i Qiwei Li. Laparoscopic nerve sparing radical hysterectomy for the treatment of cervical cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2021. http://dx.doi.org/10.37766/inplasy2021.9.0047.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Li, Yue, Zhen Gong, Longbiao Zhu, Jing Han i Hanzi Xu. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Cervical Intraepithelial Neoplasia and early Cervical Cancer : A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2023. http://dx.doi.org/10.37766/inplasy2023.4.0053.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Chen, Xuefeng, Haoyu Wang i Yu Wang. The diagnostic value of liquid biopsy for cervical cancer: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0122.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Huang, Kecheng, Yindi Bao i Hailong Huang. Acupuncture for chemotherapy-induced myelosuppression of cervical cancer: A protocol for systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0101.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Guo, Yaru, Mingna Xu i Miao Fang. Recombinant human adenovirus-p53 therapy for the treatment of cervical cancer : a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2021. http://dx.doi.org/10.37766/inplasy2021.5.0058.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Cervical Cancer” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii